Document Detail

Emergency contraception.
MedLine Citation:
PMID:  10959448     Owner:  NLM     Status:  MEDLINE    
High rates of adolescent pregnancy remain a challenge for health care providers. For most sexually active adolescents, pregnancy is unintended. Emergency contraception, also called the "morning-after-pill" or postcoital contraception, is a way to prevent pregnancy after unprotected intercourse. In the United States, three forms of emergency contraception currently are available: high-dose combination estrogen and progestin pills, high-dose progestin-only pills, and postcoital insertion of a copper intrauterine device. The postcoital intrauterine device is used infrequently. When emergency contraceptive pills (ECPs) are taken within 72 hours of unprotected intercourse, they reduce the risk of pregnancy by at least 75%. However, they are most effective if taken within 24 hours of coitus. Eleven brands of pills currently are marketed in the United States that conform to the regimens approved by the Food and Drug Administration (FDA) for this indication. Recently, two prepackaged ECPs were approved by the FDA. The only medical contraindication to prescribing ECPs is pregnancy. The most common side effects are nausea and vomiting, followed by menstrual disturbances, breast tenderness, abdominal cramping, dizziness, headache, and mood changes. Because vomiting can compromise the efficacy of ECPs, routine pretreatment with an antiemetic is recommended. Primary care providers can reduce unintended adolescent pregnancy by routinely counseling adolescents at all office visits about the existence of emergency contraception and by prescribing it in advance and over the telephone.
M A Gold
Related Documents :
7302778 - The multiload intra-uterine contraceptive device. comparison of 4 different models.
16772888 - Novel pachometry calibration.
12137678 - Sponge versus diaphragm for contraception.
14747178 - Is previous use of hormonal contraception associated with a detrimental effect on subse...
7805928 - Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ov...
25243108 - Thyrotoxicosis of pregnancy.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Advances in pediatrics     Volume:  47     ISSN:  0065-3101     ISO Abbreviation:  Adv Pediatr     Publication Date:  2000  
Date Detail:
Created Date:  2001-01-16     Completed Date:  2001-01-16     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0370436     Medline TA:  Adv Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  309-34     Citation Subset:  IM    
University of Pittsburgh School of Medicine, Pa., USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Contraceptives, Oral, Combined
Contraceptives, Postcoital* / administration & dosage,  adverse effects
Estrogens / administration & dosage
Follow-Up Studies
Physician's Role
Pregnancy, Unwanted
Progesterone / administration & dosage
Treatment Failure
United States
Reg. No./Substance:
0/Contraceptives, Oral, Combined; 0/Contraceptives, Postcoital; 0/Estrogens; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Asthma: the new advances.
Next Document:  Antivirals other than for HIV therapy.